Iron bioavailability as a protective factor against anemia among children aged 12 to 16 months

Márcia Regina Vitolo1, Gisele Ane Bortolini

  • 1Fundação Faculdade Federal de Ciências Médicas de Porto Alegre (FFFCMPA), Porto Alegre, RS, Brazil. marciavitolo@hotmail.com

Jornal De Pediatria
|February 7, 2007
PubMed

Insights

A diet rich in iron and vitamin C, with high bioavailability, significantly protects infants from anemia. This nutritional approach is crucial for early childhood development, especially in vulnerable populations.

Area of Science:

  • Nutrition Science
  • Pediatric Health
  • Public Health Interventions

Background:

  • Anemia is a significant public health concern in infants, particularly among low socioeconomic populations.
  • Nutritional interventions aim to improve health outcomes, but specific factors protecting against anemia require further investigation.
  • Understanding the role of dietary iron and bioavailability is critical for preventing anemia in early childhood.

Purpose of the Study:

  • To identify nutritional factors associated with the absence of anemia in infants from low socioeconomic backgrounds.
  • To evaluate iron intake adequacy in infants participating in a nutrition intervention program.
  • To determine the impact of dietary iron bioavailability on anemia prevention in infants.

Main Methods:

  • A cohort study involving 369 infants in Brazil, randomized into intervention and control groups.
  • The intervention group received nutritional guidance and monthly home visits during the first year of life.
  • Anemia diagnosis was based on hemoglobin levels (<11 g/dL), with dietary assessment using 24-hour recalls and iron bioavailability classification.

Main Results:

  • The prevalence of anemia was high at 63.7%.
  • Non-anemic infants showed a statistically significant higher proportion of adequate iron intake (26.8% vs. 17.7%).
  • Key protective factors included greater intake of iron, vitamin C, higher energy density at dinner, and diets with high iron bioavailability.

Conclusions:

  • A diet characterized by high iron bioavailability is a protective factor against anemia in infants.
  • Nutritional interventions focusing on iron-rich diets with enhanced bioavailability can be effectively implemented by health services and educational bodies.
  • Improving dietary iron absorption is a viable strategy for public health initiatives aimed at preventing childhood anemia.
Abstract

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bioavailability: Influencing Factors01:22

Bioavailability: Influencing Factors

Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...